Repligen Corp at Jefferies Healthcare Conference (Virtual) Transcript

Jun 03, 2021 / 06:30PM GMT
Brandon Couillard - Jefferies LLC, Research Division - Equity Analyst

All right. We'll go ahead and get started. Thanks, everyone, for joining us. Welcome to the Jefferies 2021 Global Healthcare Conference. I'm Brandon Couillard. I cover the Life Science Tools and Diagnostics sector here at the firm. It's my great pleasure to have Repligen with us back at the conference this year. Joining us for this conversation this afternoon, CEO, Tony Hunt; CFO, Jon Snodgres. Gentlemen, thanks for being here.

Anthony J. Hunt - Repligen Corporation - CEO, President & Director

Thanks, Brandon.

Questions and Answers:

Brandon Couillard - Jefferies LLC, Research Division - Equity Analyst

Tony, to jump in and kick-off. I think one of the certainly biggest debates and conversations among investors right now is just kind of what does the vaccine-related revenue picture look like second half of this year, but also into '22? Just near term, you did $35 million in the first quarter, kind of pointed to about $150 million at the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot